Long non-coding RNA LINC00240 promotes gastric cancer progression via modulating miR-338-5p/METTL3 axis

References

• Wadhwa R, Song S, Lee J-S, et al. Gastric cancer—molecular and clinical dimensions. Nat Rev Clin Oncol. 2013;10(11):643.
   PubMed Web of Science ®Google Scholar
• Topi S, Santacroce L, Bottalico L, et al. Gastric cancer in history: a perspective interdisciplinary study. Cancers (Basel). 2020;12(2):264.
   PubMed Web of Science ®Google Scholar
• Laurent GS, Wahlestedt C, Kapranov P. The Landscape of long noncoding RNA classification. Trends Genet. 2015;31(5):239–251.
   PubMed Web of Science ®Google Scholar
• Gibb EA, Brown CJ, Lam WL. The functional role of long non-coding RNA in human carcinomas. Mol Cancer. 2011;10(1):1–17.
   PubMedGoogle Scholar
• Rinn JL, Kertesz M, Wang JK, et al. Functional demarcation of active and silent chromatin domains in human HOX loci by noncoding RNAs. Cell. 2007;129(7):1311–1323.
   PubMed Web of Science ®Google Scholar
• Ji P, Diederichs S, Wang W, et al. MALAT-1, a novel noncoding RNA, and thymosin β 4 predict metastasis and survival in early-stage non-small cell lung cancer. Oncogene. 2003;22(39):8031–8041.
   PubMed Web of Science ®Google Scholar
• Koshimizu T-A, Fujiwara Y, Sakai N, et al. Oxytocin stimulates expression of a noncoding RNA tumor marker in a human neuroblastoma cell line. Life Sci. 2010;86(11–12):455–460.
   PubMed Web of Science ®Google Scholar
• Guo F, Li Y, Liu Y, et al. Inhibition of metastasis-associated lung adenocarcinoma transcript 1 in CaSki human cervical cancer cells suppresses cell proliferation and invasion. Acta Biochim Biophys Sin. 2010;42(3):224–229.
   Google Scholar
• Ku GW, Kang Y, Yu S-L, et al. LncRNA LINC00240 suppresses invasion and migration in non-small cell lung cancer by sponging miR-7-5p. BMC Cancer. 2021 Jan 9;21(1):44.
   PubMed Web of Science ®Google Scholar
• Li Y, Yan J, Wang Y, et al. LINC00240 promotes gastric cancer cell proliferation, migration and EMT via the miR‐124‐3p/DNMT3B axis. Cell Biochem Funct. 2020;38(8):1079–1088.
   PubMedGoogle Scholar
• Lin W-C, Chen L-H, Hsieh Y-C, et al. miR-338-5p inhibits cell proliferation, colony formation, migration and cisplatin resistance in esophageal squamous cancer cells by targeting FERMT2. Carcinogenesis. 2019;40(7):883–892.
   PubMed Web of Science ®Google Scholar
• Lei D, Zhang F, Yao D, et al. MiR-338-5p suppresses proliferation, migration, invasion, and promote apoptosis of glioblastoma cells by directly targeting EFEMP1. Biomed Pharmacother. 2017;89:957–965.
   PubMed Web of Science ®Google Scholar
• Park M, Yoon H-J, Kang MC, et al. MiR-338-5p enhances the radiosensitivity of esophageal squamous cell carcinoma by inducing apoptosis through targeting survivin. Sci Rep. 2017;7(1):1–9.
   PubMedGoogle Scholar
• Tong D, Zhao L, He K, et al. MECP2 promotes the growth of gastric cancer cells by suppressing miR-338-mediated antiproliferative effect. Oncotarget. 2016;7(23):34845–34859.
   PubMedGoogle Scholar
• Xing Z, Yu L, Li X, et al. Anticancer bioactive peptide-3 inhibits human gastric cancer growth by targeting miR-338-5p. Cell Biosci. 2016 Sept 22;6(1):53.
   PubMedGoogle Scholar
• Huang N, Wu Z, Lin L, et al. MiR-338-3p inhibits epithelial-mesenchymal transition in gastric cancer cells by targeting ZEB2 and MACC1/Met/Akt signaling. Oncotarget. 2015;6(17):15222.
   PubMedGoogle Scholar
• Zeng C, Huang W, Li Y, et al. Roles of METTL3 in cancer: mechanisms and therapeutic targeting. J Hematol Oncol. 2020 Aug 27;13(1):117.
   PubMed Web of Science ®Google Scholar
• Wang Q, Chen C, Ding Q, et al. METTL3-mediated m6A modification of HDGF mRNA promotes gastric cancer progression and has prognostic significance. Gut. 2020;69(7):1193–1205.
   PubMed Web of Science ®Google Scholar
• Yue B, Song C, Yang L, et al. METTL3-mediated N6-methyladenosine modification is critical for epithelial-mesenchymal transition and metastasis of gastric cancer. Mol Cancer. 2019 Oct 13;18(1):142.
   PubMed Web of Science ®Google Scholar
• Yan J, Huang X, Zhang X, et al. LncRNA LINC00470 promotes the degradation of PTEN mRNA to facilitate malignant behavior in gastric cancer cells. Biochem Biophys Res Commun. 2020;521(4):887–893.
   PubMed Web of Science ®Google Scholar
• He H, Wu W, Sun Z, et al. MiR-4429 prevented gastric cancer progression through targeting METTL3 to inhibit m6A-caused stabilization of SEC62. Biochem Biophys Res Commun. 2019;517(4):581–587.
   PubMed Web of Science ®Google Scholar
• Wu H, Li F, Zhu R. miR-338-5p inhibits cell growth and migration via inhibition of the METTL3/m6A/c-Myc pathway in lung cancer. Acta Biochim Biophys Sin (Shanghai). 2020;53(3):304–316.
   Web of Science ®Google Scholar
• Yang G, Lu X, Yuan L. LncRNA: a link between RNA and cancer. Biochimica Et Biophysica Acta (Bba)-gene Regul Mech. 2014;1839(11):1097–1109.
   PubMed Web of Science ®Google Scholar
• Luo J, Xiang H. LncRNA MYLK-AS1 acts as an oncogene by epigenetically silencing large tumor suppressor 2 (LATS2) in gastric cancer. Bioengineered. 2021;12(1):3101–3112.
   PubMed Web of Science ®Google Scholar
• Hu N, Ji H. N6-methyladenosine (m6A)-mediated up-regulation of long noncoding RNA LINC01320 promotes the proliferation, migration, and invasion of gastric cancer via miR495-5p/RAB19 axis. Bioengineered. 2021;12(1):4081–4091.
   PubMed Web of Science ®Google Scholar
• Ku GW, Kang Y, Yu S-L, et al. LncRNA LINC00240 suppresses invasion and migration in non-small cell lung cancer by sponging miR-7-5p. BMC Cancer. 2021;21(1):1–13.
   PubMed Web of Science ®Google Scholar
• Bu W, Fang Z, Li W, et al. LINC00240 sponges miR-4465 to promote proliferation, migration, and invasion of hepatocellular carcinoma cells via HGF/c-MET signaling pathway. Eur Rev Med Pharmacol Sci. 2020;24(20):10452–10461.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Li X, Zhang J, et al. Natural killer T cell cytotoxic activity in cervical cancer is facilitated by the LINC00240/microRNA-124-3p/STAT3/MICA axis. Cancer Lett. 2020;474:63–73.
   PubMed Web of Science ®Google Scholar
• Guo B, Liu L, Yao J, et al. miR-338-3p suppresses gastric cancer progression through a PTEN-AKT axis by targeting P-REX2a. Mol Cancer Res. 2014;12(3):313–321.
   PubMed Web of Science ®Google Scholar
• Yue B, Song C, Yang L, et al. METTL3-mediated N6-methyladenosine modification is critical for epithelial-mesenchymal transition and metastasis of gastric cancer. Mol Cancer. 2019;18(1):1–15.
   PubMed Web of Science ®Google Scholar